Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Limitless Projects Reports Fiscal Year Ended July 31, 2026

Limitless Projects Inc. filed its annual report on Form 10-K for the fiscal year ended July 31, 2026, disclosing its status as an early-stage Wyoming-incorporated software development company with operations based in Nairobi, Kenya.

Anjali Anand | 03 November 2026

Crown Equity Holdings Q3 2026: Net Loss of $93,715

Crown Equity Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting a nine-month net loss of $93,715 and total assets of $9,717 as of that date.

Shwetambri Chauhan | 03 November 2026

Fusemachines Q3 2026: Revenue $1.845M, Net Loss Widens

Fusemachines Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 3, 2026, reporting revenue of $1.845 million for the three months ended September 30, 2026, and a continuing stockholders' deficit.

Anjali Anand | 03 November 2026

Waters Acquires MOBILion Systems for SLIM Ion Mobility Tech

Waters Corporation filed an 8-K announcing its acquisition of MOBILion Systems, Inc., the developer of SLIM high-resolution ion mobility separation technology, on November 3, 2026.

Manish Choudhary | 03 November 2026

Lazard Closes Campbell Lutyens Deal, Launches Lazard CL

Lazard, Inc. announced on November 3, 2026, the completion of its acquisition of Campbell Lutyens and the launch of Lazard CL, a new private-capital advisory subsidiary, with the transaction originally announced on April 30, 2026.

Shwetambri Chauhan | 03 November 2026

Jason Okazaki Files to Sell 6,202 Assembly Biosciences Shares

Assembly Biosciences, Inc. officer and director Jason A. Okazaki filed a Form 144 notice on November 2, 2026, proposing to sell 6,202 shares of common stock on Nasdaq following a restricted stock unit release.

Aditi Sarkar | 02 November 2026

Director Thomas Winter Buys 10,000 RSI Shares at $11.831

Rush Street Interactive, Inc. director Thomas Winter filed a Form 4 on November 2, 2026, disclosing an open-market purchase of 10,000 shares of Class A Common Stock on that same date.

Nitish Kishor | 02 November 2026

Ewald Sells 1,245 Medpace Shares at $690 on Oct 29

Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, Inc., filed a Form 4 on November 2, 2026, disclosing the sale of 1,245 shares of common stock on October 29, 2026.

Nitish Kishor | 02 November 2026

Cytokinetics CEO Blum Exercises 7,500 Options, Sells Shares Nov 2026

Robert I. Blum, President and CEO of Cytokinetics Inc., filed a Form 4 on November 2, 2026, reporting the exercise of 7,500 stock options and the same-day sale of 7,500 shares of common stock pursuant to a Rule 10b5-1 plan.

Shwetambri Chauhan | 02 November 2026

Smith Receives 1,160 Shares via Trust Distribution at Northern Trust

Director David Byron Smith Jr. filed a Form 4 with the SEC on November 2, 2026, disclosing a change in beneficial ownership of Northern Trust Corp common stock resulting from a trust distribution on October 30, 2026.

Anjali Anand | 02 November 2026
Support

Hi! How can we help you today?

Loading…